MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3′ untranslated region

MicroRNAs (miRNAs) are a class of noncoding small RNAs that act as negative regulators of gene expression. To identify miRNAs that may regulate human cell immortalization and carcinogenesis, we performed comparative miRNA array profiling of human normal and SV40-T antigen immortalized cells. We foun...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nucleic acids research 2011-10, Vol.39 (18), p.8078-8091
Hauptverfasser: Yoon, A-rum, Gao, Ran, Kaul, Zeenia, Choi, Il-Kyu, Ryu, Jihoon, Noble, Jane R., Kato, Yoshio, Saito, Soichiro, Hirano, Takashi, Ishii, Tetsuro, Reddel, Roger R., Yun, Chae-Ok, Kaul, Sunil C., Wadhwa, Renu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 8091
container_issue 18
container_start_page 8078
container_title Nucleic acids research
container_volume 39
creator Yoon, A-rum
Gao, Ran
Kaul, Zeenia
Choi, Il-Kyu
Ryu, Jihoon
Noble, Jane R.
Kato, Yoshio
Saito, Soichiro
Hirano, Takashi
Ishii, Tetsuro
Reddel, Roger R.
Yun, Chae-Ok
Kaul, Sunil C.
Wadhwa, Renu
description MicroRNAs (miRNAs) are a class of noncoding small RNAs that act as negative regulators of gene expression. To identify miRNAs that may regulate human cell immortalization and carcinogenesis, we performed comparative miRNA array profiling of human normal and SV40-T antigen immortalized cells. We found that miR-296 was upregulated in immortalized cells that also had activation of telomerase. By an independent experiment on genomic analysis of cancer cells we found that chromosome region (20q13.32), where miR-296 is located, was amplified in 28/36 cell lines, and most of these showed enriched miR-296 expression. Overexpression of miR-296 in human cancer cells, with and without telomerase activity, had no effect on their telomerase function. Instead, it suppressed p53 function that is frequently downregulated during human cell immortalization and carcinogenesis. By monitoring the activity of a luciferase reporter connected to p53 and p21WAF1 (p21) untranslated regions (UTRs), we demonstrate that miR-296 interacts with the p21-3′UTR, and the Hu binding site of p21-3′UTR was identified as a potential miR-296 target site. We demonstrate for the first time that miR-296 is frequently upregulated during immortalization of human cells and contributes to carcinogenesis by downregulation of p53-p21WAF1 pathway.
doi_str_mv 10.1093/nar/gkr492
format Article
fullrecord <record><control><sourceid>oup_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3185413</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/nar/gkr492</oup_id><sourcerecordid>10.1093/nar/gkr492</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2522-2c24877a1be8e27b0a3e53a2e1bb9603b80e2a2c1a80ae6d99c6c9f0b07092d43</originalsourceid><addsrcrecordid>eNp9kc1OGzEURq2qVUmBDQ9QecOm0hTfa8-PN0hRVNpKQCUEYjnyeG4StxPPyJ4A3bHoE_FIPEkdBVDZdGVZPt_x1f0YOwDxGYSWR96Eo8WvoDS-YROQBWZKF_iWTYQUeQZCVTvsQ4w_hQAFuXrPdhBKVAXAhP05czb0F-fTDHXBXeTkg7NLarnz3BpvKXBLXRe58S1v-1sfaLHuzEiRDwjX0xPgqxTndDcEitH1nt84k9IjBWPHzf3WjUvuxsjl4_0DX_sxGB83ipYnWSL22Lu56SLtP5277Orky-XsW3b64-v32fQ0s5gjZmhRVWVpoKGKsGyEkZRLgwRNowshm0oQGrRgKmGoaLW2hdVz0YhSaGyV3GXHW--wblbUWtqM0tVDcCsTfte9cfXrF--W9aK_qSVUuQKZBJ-2grSzGAPNX7Ig6k0Xdeqi3naR4I___vaCPi8_AYdboF8P_xP9Bc2ZlXo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3′ untranslated region</title><source>Oxford Journals Open Access Collection</source><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Yoon, A-rum ; Gao, Ran ; Kaul, Zeenia ; Choi, Il-Kyu ; Ryu, Jihoon ; Noble, Jane R. ; Kato, Yoshio ; Saito, Soichiro ; Hirano, Takashi ; Ishii, Tetsuro ; Reddel, Roger R. ; Yun, Chae-Ok ; Kaul, Sunil C. ; Wadhwa, Renu</creator><creatorcontrib>Yoon, A-rum ; Gao, Ran ; Kaul, Zeenia ; Choi, Il-Kyu ; Ryu, Jihoon ; Noble, Jane R. ; Kato, Yoshio ; Saito, Soichiro ; Hirano, Takashi ; Ishii, Tetsuro ; Reddel, Roger R. ; Yun, Chae-Ok ; Kaul, Sunil C. ; Wadhwa, Renu</creatorcontrib><description>MicroRNAs (miRNAs) are a class of noncoding small RNAs that act as negative regulators of gene expression. To identify miRNAs that may regulate human cell immortalization and carcinogenesis, we performed comparative miRNA array profiling of human normal and SV40-T antigen immortalized cells. We found that miR-296 was upregulated in immortalized cells that also had activation of telomerase. By an independent experiment on genomic analysis of cancer cells we found that chromosome region (20q13.32), where miR-296 is located, was amplified in 28/36 cell lines, and most of these showed enriched miR-296 expression. Overexpression of miR-296 in human cancer cells, with and without telomerase activity, had no effect on their telomerase function. Instead, it suppressed p53 function that is frequently downregulated during human cell immortalization and carcinogenesis. By monitoring the activity of a luciferase reporter connected to p53 and p21WAF1 (p21) untranslated regions (UTRs), we demonstrate that miR-296 interacts with the p21-3′UTR, and the Hu binding site of p21-3′UTR was identified as a potential miR-296 target site. We demonstrate for the first time that miR-296 is frequently upregulated during immortalization of human cells and contributes to carcinogenesis by downregulation of p53-p21WAF1 pathway.</description><identifier>ISSN: 0305-1048</identifier><identifier>EISSN: 1362-4962</identifier><identifier>DOI: 10.1093/nar/gkr492</identifier><identifier>PMID: 21724611</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>3' Untranslated Regions ; Cell Line ; Cell Line, Tumor ; Cell Transformation, Neoplastic ; Cyclin-Dependent Kinase Inhibitor p21 - antagonists &amp; inhibitors ; Cyclin-Dependent Kinase Inhibitor p21 - genetics ; Cyclin-Dependent Kinase Inhibitor p21 - metabolism ; Down-Regulation ; Humans ; MicroRNAs - metabolism ; Neoplasms - genetics ; RNA ; RNA, Messenger - metabolism ; Tumor Suppressor Protein p53 - antagonists &amp; inhibitors ; Up-Regulation</subject><ispartof>Nucleic acids research, 2011-10, Vol.39 (18), p.8078-8091</ispartof><rights>The Author(s) 2011. Published by Oxford University Press. 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2522-2c24877a1be8e27b0a3e53a2e1bb9603b80e2a2c1a80ae6d99c6c9f0b07092d43</citedby><cites>FETCH-LOGICAL-c2522-2c24877a1be8e27b0a3e53a2e1bb9603b80e2a2c1a80ae6d99c6c9f0b07092d43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185413/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185413/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,1598,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21724611$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yoon, A-rum</creatorcontrib><creatorcontrib>Gao, Ran</creatorcontrib><creatorcontrib>Kaul, Zeenia</creatorcontrib><creatorcontrib>Choi, Il-Kyu</creatorcontrib><creatorcontrib>Ryu, Jihoon</creatorcontrib><creatorcontrib>Noble, Jane R.</creatorcontrib><creatorcontrib>Kato, Yoshio</creatorcontrib><creatorcontrib>Saito, Soichiro</creatorcontrib><creatorcontrib>Hirano, Takashi</creatorcontrib><creatorcontrib>Ishii, Tetsuro</creatorcontrib><creatorcontrib>Reddel, Roger R.</creatorcontrib><creatorcontrib>Yun, Chae-Ok</creatorcontrib><creatorcontrib>Kaul, Sunil C.</creatorcontrib><creatorcontrib>Wadhwa, Renu</creatorcontrib><title>MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3′ untranslated region</title><title>Nucleic acids research</title><addtitle>Nucleic Acids Res</addtitle><description>MicroRNAs (miRNAs) are a class of noncoding small RNAs that act as negative regulators of gene expression. To identify miRNAs that may regulate human cell immortalization and carcinogenesis, we performed comparative miRNA array profiling of human normal and SV40-T antigen immortalized cells. We found that miR-296 was upregulated in immortalized cells that also had activation of telomerase. By an independent experiment on genomic analysis of cancer cells we found that chromosome region (20q13.32), where miR-296 is located, was amplified in 28/36 cell lines, and most of these showed enriched miR-296 expression. Overexpression of miR-296 in human cancer cells, with and without telomerase activity, had no effect on their telomerase function. Instead, it suppressed p53 function that is frequently downregulated during human cell immortalization and carcinogenesis. By monitoring the activity of a luciferase reporter connected to p53 and p21WAF1 (p21) untranslated regions (UTRs), we demonstrate that miR-296 interacts with the p21-3′UTR, and the Hu binding site of p21-3′UTR was identified as a potential miR-296 target site. We demonstrate for the first time that miR-296 is frequently upregulated during immortalization of human cells and contributes to carcinogenesis by downregulation of p53-p21WAF1 pathway.</description><subject>3' Untranslated Regions</subject><subject>Cell Line</subject><subject>Cell Line, Tumor</subject><subject>Cell Transformation, Neoplastic</subject><subject>Cyclin-Dependent Kinase Inhibitor p21 - antagonists &amp; inhibitors</subject><subject>Cyclin-Dependent Kinase Inhibitor p21 - genetics</subject><subject>Cyclin-Dependent Kinase Inhibitor p21 - metabolism</subject><subject>Down-Regulation</subject><subject>Humans</subject><subject>MicroRNAs - metabolism</subject><subject>Neoplasms - genetics</subject><subject>RNA</subject><subject>RNA, Messenger - metabolism</subject><subject>Tumor Suppressor Protein p53 - antagonists &amp; inhibitors</subject><subject>Up-Regulation</subject><issn>0305-1048</issn><issn>1362-4962</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><sourceid>EIF</sourceid><recordid>eNp9kc1OGzEURq2qVUmBDQ9QecOm0hTfa8-PN0hRVNpKQCUEYjnyeG4StxPPyJ4A3bHoE_FIPEkdBVDZdGVZPt_x1f0YOwDxGYSWR96Eo8WvoDS-YROQBWZKF_iWTYQUeQZCVTvsQ4w_hQAFuXrPdhBKVAXAhP05czb0F-fTDHXBXeTkg7NLarnz3BpvKXBLXRe58S1v-1sfaLHuzEiRDwjX0xPgqxTndDcEitH1nt84k9IjBWPHzf3WjUvuxsjl4_0DX_sxGB83ipYnWSL22Lu56SLtP5277Orky-XsW3b64-v32fQ0s5gjZmhRVWVpoKGKsGyEkZRLgwRNowshm0oQGrRgKmGoaLW2hdVz0YhSaGyV3GXHW--wblbUWtqM0tVDcCsTfte9cfXrF--W9aK_qSVUuQKZBJ-2grSzGAPNX7Ig6k0Xdeqi3naR4I___vaCPi8_AYdboF8P_xP9Bc2ZlXo</recordid><startdate>201110</startdate><enddate>201110</enddate><creator>Yoon, A-rum</creator><creator>Gao, Ran</creator><creator>Kaul, Zeenia</creator><creator>Choi, Il-Kyu</creator><creator>Ryu, Jihoon</creator><creator>Noble, Jane R.</creator><creator>Kato, Yoshio</creator><creator>Saito, Soichiro</creator><creator>Hirano, Takashi</creator><creator>Ishii, Tetsuro</creator><creator>Reddel, Roger R.</creator><creator>Yun, Chae-Ok</creator><creator>Kaul, Sunil C.</creator><creator>Wadhwa, Renu</creator><general>Oxford University Press</general><scope>TOX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>201110</creationdate><title>MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3′ untranslated region</title><author>Yoon, A-rum ; Gao, Ran ; Kaul, Zeenia ; Choi, Il-Kyu ; Ryu, Jihoon ; Noble, Jane R. ; Kato, Yoshio ; Saito, Soichiro ; Hirano, Takashi ; Ishii, Tetsuro ; Reddel, Roger R. ; Yun, Chae-Ok ; Kaul, Sunil C. ; Wadhwa, Renu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2522-2c24877a1be8e27b0a3e53a2e1bb9603b80e2a2c1a80ae6d99c6c9f0b07092d43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>3' Untranslated Regions</topic><topic>Cell Line</topic><topic>Cell Line, Tumor</topic><topic>Cell Transformation, Neoplastic</topic><topic>Cyclin-Dependent Kinase Inhibitor p21 - antagonists &amp; inhibitors</topic><topic>Cyclin-Dependent Kinase Inhibitor p21 - genetics</topic><topic>Cyclin-Dependent Kinase Inhibitor p21 - metabolism</topic><topic>Down-Regulation</topic><topic>Humans</topic><topic>MicroRNAs - metabolism</topic><topic>Neoplasms - genetics</topic><topic>RNA</topic><topic>RNA, Messenger - metabolism</topic><topic>Tumor Suppressor Protein p53 - antagonists &amp; inhibitors</topic><topic>Up-Regulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yoon, A-rum</creatorcontrib><creatorcontrib>Gao, Ran</creatorcontrib><creatorcontrib>Kaul, Zeenia</creatorcontrib><creatorcontrib>Choi, Il-Kyu</creatorcontrib><creatorcontrib>Ryu, Jihoon</creatorcontrib><creatorcontrib>Noble, Jane R.</creatorcontrib><creatorcontrib>Kato, Yoshio</creatorcontrib><creatorcontrib>Saito, Soichiro</creatorcontrib><creatorcontrib>Hirano, Takashi</creatorcontrib><creatorcontrib>Ishii, Tetsuro</creatorcontrib><creatorcontrib>Reddel, Roger R.</creatorcontrib><creatorcontrib>Yun, Chae-Ok</creatorcontrib><creatorcontrib>Kaul, Sunil C.</creatorcontrib><creatorcontrib>Wadhwa, Renu</creatorcontrib><collection>Oxford Journals Open Access Collection</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Nucleic acids research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yoon, A-rum</au><au>Gao, Ran</au><au>Kaul, Zeenia</au><au>Choi, Il-Kyu</au><au>Ryu, Jihoon</au><au>Noble, Jane R.</au><au>Kato, Yoshio</au><au>Saito, Soichiro</au><au>Hirano, Takashi</au><au>Ishii, Tetsuro</au><au>Reddel, Roger R.</au><au>Yun, Chae-Ok</au><au>Kaul, Sunil C.</au><au>Wadhwa, Renu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3′ untranslated region</atitle><jtitle>Nucleic acids research</jtitle><addtitle>Nucleic Acids Res</addtitle><date>2011-10</date><risdate>2011</risdate><volume>39</volume><issue>18</issue><spage>8078</spage><epage>8091</epage><pages>8078-8091</pages><issn>0305-1048</issn><eissn>1362-4962</eissn><abstract>MicroRNAs (miRNAs) are a class of noncoding small RNAs that act as negative regulators of gene expression. To identify miRNAs that may regulate human cell immortalization and carcinogenesis, we performed comparative miRNA array profiling of human normal and SV40-T antigen immortalized cells. We found that miR-296 was upregulated in immortalized cells that also had activation of telomerase. By an independent experiment on genomic analysis of cancer cells we found that chromosome region (20q13.32), where miR-296 is located, was amplified in 28/36 cell lines, and most of these showed enriched miR-296 expression. Overexpression of miR-296 in human cancer cells, with and without telomerase activity, had no effect on their telomerase function. Instead, it suppressed p53 function that is frequently downregulated during human cell immortalization and carcinogenesis. By monitoring the activity of a luciferase reporter connected to p53 and p21WAF1 (p21) untranslated regions (UTRs), we demonstrate that miR-296 interacts with the p21-3′UTR, and the Hu binding site of p21-3′UTR was identified as a potential miR-296 target site. We demonstrate for the first time that miR-296 is frequently upregulated during immortalization of human cells and contributes to carcinogenesis by downregulation of p53-p21WAF1 pathway.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>21724611</pmid><doi>10.1093/nar/gkr492</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0305-1048
ispartof Nucleic acids research, 2011-10, Vol.39 (18), p.8078-8091
issn 0305-1048
1362-4962
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3185413
source Oxford Journals Open Access Collection; MEDLINE; DOAJ Directory of Open Access Journals; PubMed Central; Free Full-Text Journals in Chemistry
subjects 3' Untranslated Regions
Cell Line
Cell Line, Tumor
Cell Transformation, Neoplastic
Cyclin-Dependent Kinase Inhibitor p21 - antagonists & inhibitors
Cyclin-Dependent Kinase Inhibitor p21 - genetics
Cyclin-Dependent Kinase Inhibitor p21 - metabolism
Down-Regulation
Humans
MicroRNAs - metabolism
Neoplasms - genetics
RNA
RNA, Messenger - metabolism
Tumor Suppressor Protein p53 - antagonists & inhibitors
Up-Regulation
title MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3′ untranslated region
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T04%3A03%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MicroRNA-296%20is%20enriched%20in%20cancer%20cells%20and%20downregulates%20p21WAF1%20mRNA%20expression%20via%20interaction%20with%20its%203%E2%80%B2%20untranslated%20region&rft.jtitle=Nucleic%20acids%20research&rft.au=Yoon,%20A-rum&rft.date=2011-10&rft.volume=39&rft.issue=18&rft.spage=8078&rft.epage=8091&rft.pages=8078-8091&rft.issn=0305-1048&rft.eissn=1362-4962&rft_id=info:doi/10.1093/nar/gkr492&rft_dat=%3Coup_pubme%3E10.1093/nar/gkr492%3C/oup_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/21724611&rft_oup_id=10.1093/nar/gkr492&rfr_iscdi=true